Literature for family I1

(Topics flags: S Structure, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

2019
1. Boros,E., Sebak,F., Heja,D., Szakacs,D., Zboray,K., Schlosser,G., Micsonai,A., Kardos,J., Bodor,A. and Pal,G.
   Directed evolution of canonical loops and their swapping between unrelated serine proteinase inhibitors disprove the interscaffolding additivity model
   J Mol Biol431, 557-575. PubMed  Europe PubMed DOI
2013
2. van Hoef,V., Breugelmans,B., Spit,J., Simonet,G., Zels,S. and Vanden Broeck,J.
   Phylogenetic distribution of protease inhibitors of the Kazal-family within the Arthropoda
   Peptides41, 59-65. PubMed  Europe PubMed DOI
2010
3. Cerenius,L., Liu,H., Zhang,Y., Rimphanitchayakit,V., Tassanakajon,A., Gunnar Andersson,M., Soderhall,K. and Soderhall,I.
   High sequence variability among hemocyte-specific Kazal-type proteinase inhibitors in decapod crustaceans
   Dev Comp Immunol34, 69-75. PubMed  Europe PubMed DOI
4. Rimphanitchayakit,V. and Tassanakajon,A.
   Structure and function of invertebrate Kazal-type serine proteinase inhibitors
   Dev Comp Immunol34, 377-386. PubMed  Europe PubMed DOI  V
2006
5. [YEAR:24-3-2006]Chakrabarty,A., Green,J.A. and Roberts,R.M.
   Origin and evolution of the TKDP gene family
   Gene373, 35-43. PubMed  Europe PubMed DOI
6. Zheng,Q.L., Sheng,Q. and Zhang,Y.Z.
   [Progresses in the structure and function of Kazal-type proteinase inhibitors]
   Sheng Wu Gong Cheng Xue Bao22, 695-700. PubMed  Europe PubMed  V
2005
7. Kelly,C.A., Laskowski,M., Jr. and Qasim,M.A.
   The role of scaffolding in standard mechanism serine proteinase inhibitors
   Protein Pept Lett12, 465-471. PubMed  Europe PubMed DOI
2004
8. [YEAR:5-1-2004]Rawlings,N.D., Tolle,D.P. and Barrett,A.J.
   Evolutionary families of peptidase inhibitors
   Biochem J378, 705-716. PubMed  Europe PubMed DOI
2001
9. [YEAR:13-2-2001]Lu,S.M., Lu,W., Qasim,M.A., Anderson,S., Apostol,I., Ardelt,W., Bigler,T., Chiang,Y.W., Cook,J., James,M.N., Kato,I., Kelly,C., Kohr,W., Komiyama,T., Lin,T.Y., Ogawa,M., Otlewski,J., Park,S.J., Qasim,S., Ranjbar,M., Tashiro,M., Warne,N., Whatley,H., Wieczorek,A., Wieczorek,M., Wilusz,T., Wynn,R., Zhang,W. and Laskowski,M., Jr.
   Predicting the reactivity of proteins from their sequence alone: Kazal family of protein inhibitors of serine proteinases
   Proc Natl Acad Sci U S A98, 1410-1415. PubMed  Europe PubMed DOI
1998
10. [YEAR:1-9-1998]Apostoluk,W. and Otlewski,J.
    Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins
    Proteins32, 459-474. PubMed  Europe PubMed DOI
1987
11. [YEAR:13-1-1987]Laskowski,M., Jr., Kato,I., Ardelt,W., Cook,J., Denton,A., Empie,M.W., Kohr,W.J., Park,S.J., Parks,K. and Schatzley,B.L.
    Ovomucoid third domains from 100 avian species: isolation, sequences, and hypervariability of enzyme-inhibitor contact residues
    Biochemistry26, 202-221. PubMed  Europe PubMed
1986
12. Read,R.J. and James,M.N.G.
    Introduction to the protein inhibitors: X-ray crystallography
    301-336.  S
1983
13. [YEAR:15-4-1983]Antonini,E., Ascenzi,P., Bolognesi,M., Gatti,G., Guarneri,M. and Menegatti,E.
    Interaction between serine (pro)enzymes, and Kazal and Kunitz inhibitors
    J Mol Biol165, 543-558. PubMed  Europe PubMed
1980
14. Laskowski,M., Jr. and Kato,I.
    Protein inhibitors of proteinases
    Annu Rev Biochem49, 593-626. PubMed  Europe PubMed DOI